Otherwise, the comparison between MAFLD patients and matched controls did not reveal any significant differences in inflammation, fibrosis or lobular/interface activity (or cytokeratin 7 positive hepatocytes for PBC and PSC) for any of the diagnosis groups. This evidence concerns the gene KRT7 and primary biliary cholangitis.